Corrigendum: Regulatory Framework for Advanced Therapy Medicinal Products in Europe and United States (Frontiers in Pharmacology, (2019), 10, 10.3389/fphar.2019.00921)

Carolina Iglesias-Lopez, Antonia Agustí, Mercè Obach*, Antonio Vallano

*Corresponding author for this work

Research output: Contribution to journalArticleResearchpeer-review

Abstract

In the original article, there was an error. In the specified paragraph, the word “latter” and “former” should be interchanged. A correction has been made to the Regulatory Framework for the Classification of Advanced Therapies section, paragraph 8:

Original languageAmerican English
Article number766
JournalFrontiers in Pharmacology
Volume11
DOIs
Publication statusPublished - 25 May 2020

Keywords

  • biological products
  • biological therapy
  • cell- and tissue-based therapy
  • Europe
  • genetic therapy
  • legislation and jurisprudence
  • tissue engineering
  • United States Food and Drug Administration

Fingerprint Dive into the research topics of 'Corrigendum: Regulatory Framework for Advanced Therapy Medicinal Products in Europe and United States (Frontiers in Pharmacology, (2019), 10, 10.3389/fphar.2019.00921)'. Together they form a unique fingerprint.

Cite this